Copper(II) complexes as potential anticancer and Nonsteroidal anti-inflammatory agents: In vitro and in vivo studies

A Hussain, MF AlAjmi, MT Rehman, S Amir… - Scientific reports, 2019 - nature.com
Copper-based compounds are promising entities for target-specific next-generation
anticancer and NSAIDS therapeutics. In lieu of this, benzimidazole scaffold plays an …

Endogenous opiates and behavior: 2016

RJ Bodnar - Peptides, 2018 - Elsevier
This paper is the thirty-ninth consecutive installment of the annual review of research
concerning the endogenous opioid system. It summarizes papers published during 2016 …

Fentanyl structure as a scaffold for opioid/non-opioid multitarget analgesics

PFJ Lipiński, J Matalińska - International Journal of Molecular Sciences, 2022 - mdpi.com
One of the strategies in the search for safe and effective analgesic drugs is the design of
multitarget analgesics. Such compounds are intended to have high affinity and activity at …

Oxytocin relieves neuropathic pain through GABA release and presynaptic TRPV1 inhibition in spinal cord

W Sun, Q Zhou, X Ba, X Feng, X Hu… - Frontiers in molecular …, 2018 - frontiersin.org
Objective: Oxytocin (OT) is synthesized within the paraventricular nucleus and supraoptic
nucleus of the hypothalamus. In addition to its role in uterine contraction, OT plays an …

OFP011 cyclic peptide as a multifunctional agonist for opioid/neuropeptide ff receptors with improved blood–brain barrier penetration

M Zhang, B Xu, N Li, R Zhang, Q Zhang… - ACS Chemical …, 2022 - ACS Publications
Mounting evidence indicates that the neuropeptide FF (NPFF) system is involved in the side
effects of opioid usage, including antinociceptive tolerance, hyperalgesia, abuse …

Development of multifunctional and orally active cyclic peptide agonists of opioid/neuropeptide FF receptors that produce potent, long-lasting, and peripherally …

M Zhang, B Xu, N Li, R Zhang, Q Zhang… - Journal of medicinal …, 2021 - ACS Publications
We previously reported that a multifunctional opioid/neuropeptide FF receptor agonist, DN-9,
achieved peripherally restricted analgesia with reduced side effects. To develop stable and …

All-Hydrocarbon Stapled Peptide Multifunctional Agonists at Opioid and Neuropeptide FF Receptors: Highly Potent, Long-Lasting Brain Permeant Analgesics with …

M Zhang, B Xu, N Li, Q Zhang, D Chen… - Journal of Medicinal …, 2023 - ACS Publications
Our previous study reported the multifunctional agonist for opioid and neuropeptide FF
receptors DN-9, along with its cyclic peptide analogues c [D-Cys2, Cys5]-DN-9 and c [D …

Neuropeptide FF and its receptors: therapeutic applications and ligand development

T Nguyen, J Marusich, JX Li… - Journal of medicinal …, 2020 - ACS Publications
The endogenous neuropeptide FF (NPFF) and its two cognate G protein-coupled receptors,
Neuropeptide FF Receptors 1 and 2 (NPFFR1 and NPFFR2), represent a relatively new …

The multifunctional peptide DN‐9 produced peripherally acting antinociception in inflammatory and neuropathic pain via μ‐and κ‐opioid receptors

B Xu, M Zhang, X Shi, R Zhang, D Chen… - British journal of …, 2020 - Wiley Online Library
Background and Purpose Considerable effort has recently been directed at developing
multifunctional opioid drugs to minimize the unwanted side effects of opioid analgesics. We …

Access to α, γ-diamino diacid derivatives via organocatalytic asymmetric 1, 4-addition of azlactones and dehydroalanines

J Yang, W Sun, Z He, C Yu, G Bao, Y Li, Y Liu… - Organic …, 2018 - ACS Publications
A convenient and functional-group-tolerant organocatalytic asymmetric 1, 4-addition of
azlactones and dehydroalanine is disclosed. The reaction is used for the first synthesis of …